Newsroom

EVRY, France--(BUSINESS WIRE)--Regulatory News : IntegraGen (FR0010908723 – ALINT – Eligible PEA PME), une société spécialisée dans la génomique du cancer et des maladies génétiques rares, qui réalise des analyses génomiques et de données, interprétables pour des laboratoires académiques et privés, fait le point sur l’audience qui s’est tenue ce jour devant le Tribunal de commerce d'Évry, dans le cadre de la procédure de redressement judiciaire ouverte le 15 juin 2026. Cette audience portait su...

سان فرانسيسكو وميامي--(BUSINESS WIRE)--اليوم، نشرت Visa (رمزها في بورصة نيويورك: V)‎ بيانات جديدة تُظهر تزايد اعتماد العملات المستقرة في مدفوعات الأعمال وبرامج البطاقات التجارية، مما يؤكد كيف يتم استخدام العملات المستقرة بشكل متزايد كبنية تحتية مالية.تأتي هذه النتائج في الوقت الذي تستكشف فيه الشركات والمؤسسات المالية ومقدمو خدمات الدفع بشكل متزايد العملات المستقرة لأغراض التسوية وإدارة الخزينة والمدفوعات والتجارة عبر الحدود.تُظهر البيانات الجديدة من Visa ما يلي:تمَّ ما يقرب من 17% من حجم عمليات...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of RXO Inc. (NYSE: RXO) to C.H. Robinson Worldwide, Inc. for $17.25 per share in cash and 0.0856 shares of C.H. Robinson common stock for each RXO share. Upon closing of the Proposed Transaction, RXO shareholders are expected to own 11% of the combined company. Halper Sadeh encourages RXO shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Ha...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zag Bio™, Inc., a biotechnology company working to set a new standard for treating autoimmune disease, today announced it has advanced its lead program for Type 1 diabetes (T1D), ZAG-101, into clinical development. The company’s first-in-human Phase 1b/2a clinical trial (LANTERN) will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of ZAG-101 and explore its potential to preserve insulin-producing beta-cell function. “Advancing ZAG-101...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming November 30, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Endava plc (“Endava” or the “Company”) (NYSE: DAVA) securities between September 4, 2025 and September 21, 2026 inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR ENDAVA PLC INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIM...

OKLAHOMA CITY--(BUSINESS WIRE)--RMS and Finalytics help healthcare providers access cash from eligible claims in three days through claims monetization and remittance support....

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming November 30, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Qfin Holdings, Inc. (“Qfin” or the “Company”) (NASDAQ: QFIN) securities between March 18, 2026 and August 25, 2026 inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR QFIN HOLDINGS, INC. INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PU...

DALLAS--(BUSINESS WIRE)--Oldcastle BuildingEnvelope, Inc. (“OBE”), a North American manufacturer, fabricator and distributor of architectural hardware, glass and glazing systems, today announced the completion of a comprehensive refinancing that provides OBE with $300 million of new capital, reduces its annual cash interest expense by approximately $50 million and extends its debt maturities to 2031. The transaction strengthens OBE’s financial position and provides additional resources to inves...

CHARLOTTESVILLE, Va. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Iron Path Capital announced the closing of Iron Path Capital Fund II with $450 million in total commitments....

DURHAM, N.C.--(BUSINESS WIRE)--The Utah Office of AI Policy announced its partnership with Vega Health to act as a third-party evaluator for its first-in-the-nation AI Sandbox....